Polymeric Nanoscale Drug Carriers Mediate the Delivery of Methotrexate for Developing Therapeutic Interventions Against Cancer and Rheumatoid Arthritis

被引:24
|
作者
Yu, Wen-Jun [1 ]
Huang, Dong-Xu [1 ]
Liu, Shuang [2 ]
Sha, Ying-Li [3 ]
Gao, Feng-hui [4 ]
Liu, Hong [5 ]
机构
[1] First Hosp Jilin Univ, Dept Hand & Foot Surg, Eastern Div, Changchun, Peoples R China
[2] First Hosp Jilin Univ, Dept Nursing Management, Eastern Div, Changchun, Peoples R China
[3] First Hosp Jilin Univ, Dept Pediat, Eastern Div, Changchun, Peoples R China
[4] First Hosp Jilin Univ, Dept Orthopaed, Eastern Div, Changchun, Peoples R China
[5] First Hosp Jilin Univ, Dept Otolaryngol, Eastern Div, Changchun, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
关键词
methotrexate; cancer; liposomes; LPHNPs; NLCs; NANOSTRUCTURED LIPID CARRIERS; IN-VIVO PHARMACOKINETICS; HYBRID NANOPARTICLES; BREAST-CANCER; TARGETED DELIVERY; CONTROLLED-RELEASE; SYSTEMS; MICELLES; NANOCARRIERS; PLATFORM;
D O I
10.3389/fonc.2020.01734
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Methotrexate (MTX) is widely used as an anticancer and anti-inflammtory drug for treating various types of cancer and autoimmune diseases. The optimal dose of MTX is known to inhibit the dihydrofolatereductase that hinders the replication of purines. The nanobiomedicine has been extensively explored in the past decade to develop myriad functional nanostructures to facilitate the delivery of therapeutic agents for various medical applications. This review is focused on understanding the design and development of MTX-loaded nanoparticles alongside the inclusion of recent findings for the treatment of cancers. In this paper, we have made a coordinated effort to show the potential of novel drug delivery systems by achieving effective and target-specific delivery of methotrexate.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis
    Samira Sadat Abolmaali
    Ali Mohammad Tamaddon
    Rassoul Dinarvand
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1115 - 1130
  • [2] A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis
    Abolmaali, Samira Sadat
    Tamaddon, Ali Mohammad
    Dinarvand, Rassoul
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1115 - 1130
  • [3] Therapeutic delivery systems for rheumatoid arthritis based on hydrogel carriers
    Chapa-Villarreal, Fabiola A.
    Stephens, Madeleine
    Pavlicin, Rachel
    Beussman, Micaela
    Peppas, Nicholas A.
    ADVANCED DRUG DELIVERY REVIEWS, 2024, 208
  • [4] Targeted drug delivery of Methotrexate in situ gels for the treatment of Rheumatoid Arthritis
    Venkatesh, Madhugiri Prakash
    Kumar, Tegginmat Pramod
    Pai, Deeksha Ramananda
    SAUDI PHARMACEUTICAL JOURNAL, 2020, 28 (12) : 1548 - 1557
  • [5] Organic nanoscale drug carriers coupled with ligands for targeted drug delivery in cancer
    Shi, Meng
    Lu, Jiao
    Shoichet, Molly S.
    JOURNAL OF MATERIALS CHEMISTRY, 2009, 19 (31) : 5485 - 5498
  • [6] Carbon Nanotubes-Potent Carriers for Targeted Drug Delivery in Rheumatoid Arthritis
    Kofoed Andersen, Camilla
    Khatri, Sangita
    Hansen, Jonas
    Slott, Sofie
    Pavan Parvathaneni, Rohith
    Mendes, Ana C.
    Chronakis, Ioannis S.
    Hung, Shu-Chen
    Rajasekaran, Narendiran
    Ma, Zhuoran
    Zhu, Shoujun
    Dai, Hongjie
    Mellins, Elizabeth D.
    Astakhova, Kira
    PHARMACEUTICS, 2021, 13 (04)
  • [7] Alginate Microsponges as a Scaffold for Delivery of a Therapeutic Peptide against Rheumatoid Arthritis
    Ariaudo, Daniela
    Cavalieri, Francesca
    Rinaldi, Antonio
    Aguilera, Ana
    Lopez, Matilde
    Perez, Hilda Garay
    Felipe, Ariel
    del Carmen Dominguez, Maria
    Ruiz, Odalys
    Martinez, Gillian
    Venanzi, Mariano
    NANOMATERIALS, 2023, 13 (19)
  • [8] Therapeutic drug monitoring of methotrexate and its polyglutamated metabolites erythrocyte concentrations in rheumatoid arthritis
    Verdier, M.
    Rihouey, D.
    Bentue-Ferrer, D.
    Perdriger, A.
    Bellissant, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 72 - 72
  • [9] Revolutionizing Therapeutic Drug Delivery: Intelligent Polymeric Systems and Hybrid Nano-carriers
    Muhamad, Ida Idayu
    MATERIALS TODAY-PROCEEDINGS, 2018, 5 : S149 - S153
  • [10] Nanoscale Polymersomes as Anti-Cancer Drug Carriers Applied for Pharmaceutical Delivery
    Tuguntaev, Ruslan G.
    Okeke, Chukwunweike Ikechukwu
    Xu, Jing
    Li, Chan
    Wang, Paul C.
    Liang, Xing-Jie
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (19) : 2857 - 2865